We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MD market cap is 1.14B. The company's latest EPS is USD -1.1543 and P/E is -17.86.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 496.44M | 495.1M | 504.3M | 511.16M | 502.36M |
| Operating Income | -111.01M | 16.41M | -157.26M | 34.27M | 77.7M |
| Net Income | -124.29M | 4.04M | -153.03M | 19.44M | 30.48M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.73B | 1.91B | 1.97B | 1.99B | 2.01B |
| Operating Income | 99.72M | 197.55M | 174.41M | 9.38M | -28.88M |
| Net Income | -796.49M | 130.96M | 66.34M | -60.41M | -99.07M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.22B | 2.17B | 2B | 2.08B | 2.15B |
| Total Liabilities | 1.37B | 1.31B | 1.29B | 1.34B | 1.39B |
| Total Equity | 849.06M | 856.2M | 706.46M | 732.49M | 764.94M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.35B | 2.72B | 2.35B | 2.22B | 2.15B |
| Total Liabilities | 2.6B | 1.83B | 1.46B | 1.37B | 1.39B |
| Total Equity | 747.72M | 896.69M | 891.63M | 849.06M | 764.94M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 137.33M | -125.23M | -18.28M | 73.56M | 206.57M |
| Investing | -48.18M | -16.24M | -29.13M | -33.47M | -35.41M |
| Financing | -25.72M | 76.2M | -6.45M | -9.52M | -14.49M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 204.62M | 76.74M | 166.94M | 137.33M | 206.57M |
| Investing | 815.51M | -53.07M | -56.95M | -48.18M | -35.41M |
| Financing | -4.16M | -760.12M | -487.55M | -25.72M | -14.49M |
| Market Cap | 1.14B |
| Price to Earnings Ratio | -17.86 |
| Price to Sales Ratio | 0.88 |
| Price to Cash Ratio | 7.7 |
| Price to Book Ratio | 2.31 |
| Dividend Yield | - |
| Shares Outstanding | 85.83M |
| Average Volume (1 week) | 777.07k |
| Average Volume (1 Month) | 662.49k |
| 52 Week Change | 44.06% |
| 52 Week High | 17.67 |
| 52 Week Low | 6.62 |
| Spread (Intraday) | 8.93 (61.04%) |
| Company Name | Pediatrix Medical Group Inc |
| Address |
1301 concord terrace sunrise, florida 33323 |
| Website | https://www.mednax.com |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
